Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Delayed
Japan Exchange
09:42:04 2026-09-15 pm EDT
|
5-day change | 1st Jan Change | ||
| 5,832.00 JPY | -0.26% |
|
+3.88% | +20.64% |
| Market Cap | 9,336B 60.19B 52.13B 49.3B 44.63B 83.77B 5,774B 84.4B 588B 226B 2,927B 226B 221B | P/E 2027 * |
46.3x | P/E 2028 * | 29.4x |
|---|---|---|---|---|---|
| Enterprise Value | 13,243B 85.37B 73.95B 69.93B 63.31B 119B 8,189B 120B 834B 321B 4,152B 321B 314B | EV / Sales 2027 * |
2.82x | EV / Sales 2028 * | 2.73x |
| Free-Float |
99.26% | Yield 2027 * |
3.49% | Yield 2028 * | 3.56% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
OTC Markets
| TKPHF | Delayed | |
Börse Stuttgart
| TKD | Delayed | |
Boerse Muenchen
| TKD | Real-time | |
Deutsche Boerse AG
| TKD | Delayed | |
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.24% | ||
| 1 week | +3.88% | ||
| Current month | +1.18% | ||
| 1 month | +5.80% | ||
| 3 months | +16.20% | ||
| 6 months | +1.67% | ||
| Current year | +20.64% |
| 1 week | 5,557 | 5,887 | |
| 1 month | 5,504 | 5,917 | |
| Current year | 4,710 | 6,033 | |
| 1 year | 4,102 | 6,033 | |
| 3 years | 3,852 | 6,033 | |
| 5 years | 2,993 | 6,033 | |
| 10 years | 2,894.5 | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2024-12-31 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Sell | Chief Technology Officer | -116,191 | 0.0073% | ||
| 8/19/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% | ||
| 8/18/26 | Sell | Head of Human Resources | -12,980 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.26% | +3.88% | +30.67% | +20.79% | 59.26B | ||
| -0.19% | +1.09% | +51.85% | +97.36% | 1,015B | ||
| +0.33% | -0.71% | +50.62% | +65.50% | 642B | ||
| +0.49% | +5.73% | +20.88% | +72.92% | 463B | ||
| -0.22% | +2.88% | +38.48% | +37.98% | 353B | ||
| -0.07% | +1.82% | +16.57% | +23.39% | 265B | ||
| -0.31% | +2.02% | +6.15% | +10.75% | 254B | ||
| -1.53% | -4.46% | +36.90% | +44.08% | 206B | ||
| -1.60% | -5.51% | -22.30% | -58.60% | 191B | ||
| +0.49% | -0.23% | +30.00% | +93.34% | 182B | ||
| Average | -0.10% | -1.04% | +25.98% | +40.75% | 362.95B | |
| Weighted average by Cap. | +0.39% | -0.01% | +34.41% | +58.67% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,701B 30.3B 26.25B 24.82B 22.47B 42.18B 2,907B 42.49B 296B 114B 1,474B 114B 111B | 4,781B 30.82B 26.7B 25.25B 22.86B 42.9B 2,957B 43.22B 301B 116B 1,499B 116B 113B |
| Net income | 196B 1.27B 1.1B 1.04B 939M 1.76B 122B 1.78B 12.38B 4.76B 61.61B 4.76B 4.65B | 322B 2.08B 1.8B 1.7B 1.54B 2.89B 199B 2.91B 20.32B 7.82B 101B 7.81B 7.63B |
| Net Debt | 3,907B 25.18B 21.81B 20.63B 18.68B 35.05B 2,416B 35.31B 246B 94.71B 1,225B 94.6B 92.5B | 3,702B 23.87B 20.67B 19.55B 17.7B 33.22B 2,289B 33.47B 233B 89.75B 1,161B 89.65B 87.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-15 | ¥5,832.00 | -0.26% | 1,335,400 |
| 26-09-15 | ¥5,847.00 | +1.92% | 4,665,400 |
| 26-09-14 | ¥5,737.00 | +1.25% | 2,846,900 |
| 26-09-11 | ¥5,666.00 | +0.16% | 4,255,100 |
| 26-09-10 | ¥5,657.00 | +0.75% | 4,493,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions


















